Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis

Current Diabetes Reports
Maria J RedondoAndrea K Steck

Abstract

About 50% of the heritability of type 1 diabetes (T1D) is attributed to human leukocyte antigen (HLA) alleles and the remainder to several (close to 50) non-HLA loci. A current challenge in the field of the genetics of T1D is to apply the knowledge accumulated in the last 40 years towards differential diagnosis and risk assessment. T1D genetic risk scores seek to combine the information from HLA and non-HLA alleles to improve the accuracy of diagnosis, prediction, and prognosis. Here, we describe genetic risk scores that have been developed and validated in various settings and populations. Several genetic scores have been proposed that merge disease risk information from multiple genetic factors to optimize the use of genetic information and ultimately improve prediction and diagnosis of T1D.

References

Jun 28, 1990·The New England Journal of Medicine·J M BaischJ D Capra
Sep 1, 1987·Diabetes Care·P VardiS Srikanta
May 22, 1986·The New England Journal of Medicine·G S Eisenbarth
Mar 1, 1985·International Journal of Epidemiology·G Rose
Nov 9, 1974·Lancet·A G Cudworth, J C Woodrow
Jun 6, 1981·British Medical Journal·G Rose
Feb 1, 1994·Diabetes Care·K J CruickshanksR F Hamman
Nov 4, 2000·The Journal of Clinical Endocrinology and Metabolism·M J RedondoK S Ronningen
Jul 31, 2001·Lancet·M A Atkinson, G S Eisenbarth
Jul 11, 2002·Diabetologia·M J Redondo, G S Eisenbarth
Sep 5, 2003·The New England Journal of Medicine·Alan E Guttmacher, Francis S Collins
Apr 29, 2004·Journal of Pediatric Endocrinology & Metabolism : JPEM·Bridget J McCarthyLynn Nichol
Feb 9, 2006·The Journal of Clinical Endocrinology and Metabolism·Maria J RedondoUNKNOWN Diabetes Prevention Trial Type 1 Study Group
Mar 1, 2006·Diabetes Care·Samy MrenaMikael Knip
Sep 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Theresa A AlyGeorge S Eisenbarth
Sep 14, 2007·Pediatric Diabetes·UNKNOWN TEDDY Study Group
Nov 15, 2007·Diabetes Care·Jay M SosenkoUNKNOWN Diabetes Prevention Trial-Type 1 Study Group
Nov 21, 2008·The New England Journal of Medicine·James B MeigsL Adrienne Cupples
Dec 26, 2008·The New England Journal of Medicine·Maria J RedondoTihamer Orban
Jan 6, 2009·Annals of the New York Academy of Sciences·Jay S SkylerUNKNOWN Type 1 Diabetes TrialNet Study Group
May 12, 2009·Nature Genetics·Jeffrey C BarrettUNKNOWN Type 1 Diabetes Genetics Consortium
Dec 4, 2009·Genes and Immunity·S S RichJ A Todd
Jan 2, 2010·Science·Francis S Collins
May 1, 2010·Nature·Jeffrey A BluestoneGeorge Eisenbarth

❮ Previous
Next ❯

Citations

Jun 21, 2019·Current Opinion in Endocrinology, Diabetes, and Obesity·Richard A Oram, Maria J Redondo
Jul 20, 2019·Endocrine Reviews·Miriam S UdlerAnubha Mahajan
Sep 15, 2019·Current Diabetes Reports·Ayo P DoumateyCharles N Rotimi
Mar 30, 2018·Frontiers in Microbiology·Maria C OpazoClaudia A Riedel
Jan 23, 2019·Diabetes Care·Karen CerolsalettiCarla J Greenbaum
Oct 15, 2019·Annals of Pediatric Endocrinology & Metabolism·Hae Sang Lee, Jin Soon Hwang
Aug 10, 2020·Nature Medicine·Lauric A FerratUNKNOWN Committees
Jul 17, 2020·Frontiers in Endocrinology·Marina PrimaveraFrancesco Chiarelli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.